lobbying_activities: 1666796
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1666796 | 90fc80f1-b0c2-42c5-8564-866238eb05f8 | Q1 | ALKERMES, INC. | 400458235 | ALKERMES, INC. | 2015 | first_quarter | PHA | DEA regulatory transparency in controlled substances scheduling person DEA regulatory transparency in issuing research licenses and quotas | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute on Alcohol Abuse & Alcoholism (NIAA),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 863000 | 0 | 0 | 2015-04-17T11:48:17.533000-04:00 |